Biotin-LEVD-FMK

Biotin-LEVD-FMK is a synthetic peptide-based inhibitor designed for the selective and irreversible inhibition of caspase enzymes, particularly caspase-4. As a biotinylated peptide analog, it incorporates the LEVD peptide recognition sequence and a fluoromethyl ketone (FMK) reactive group, enabling both targeted enzyme inhibition and affinity-based detection. The addition of a biotin moiety allows for subsequent capture or visualization using streptavidin-based systems, making it a valuable tool in apoptosis research, protease activity profiling, and mechanistic studies of programmed cell death pathways. Its utility lies in its dual functional design, combining potent enzyme targeting with robust biochemical tagging for downstream analysis.

Enzyme inhibition studies: Biotin-LEVD-FMK is widely employed in the investigation of caspase-4 and related protease activity within cell extracts or in vitro systems. By covalently binding to the active site cysteine of target caspases, the FMK group effectively blocks enzymatic function, enabling researchers to dissect the specific contributions of these proteases to apoptotic signaling. Such targeted inhibition facilitates the elucidation of caspase-dependent pathways and aids in distinguishing the roles of individual caspases within complex cellular responses.

Affinity labeling and pull-down assays: The biotinylated nature of this peptide inhibitor enables its use in affinity-based enrichment techniques. After binding to active caspase enzymes, the biotin tag permits subsequent isolation of labeled proteases via streptavidin-conjugated beads or surfaces. This approach supports the identification and characterization of caspase-4 and its interacting partners from biological samples, providing insights into the composition and dynamics of apoptotic complexes under various experimental conditions.

Protease activity profiling: In cell-based or biochemical assays, Biotin-LEVD-FMK serves as a functional probe for monitoring the activation status of caspase-4. By selectively labeling the active form of the enzyme, it allows for quantitative and qualitative assessment of protease dynamics during apoptosis induction, stress responses, or immune signaling. Detection via biotin-streptavidin systems further enhances sensitivity and specificity, supporting detailed temporal and spatial mapping of caspase activity.

Mechanistic studies of apoptosis: The compound is instrumental in dissecting the molecular mechanisms underlying programmed cell death, especially in models where caspase-4 plays a pivotal role. By selectively inhibiting this protease, researchers can assess downstream effects on substrate cleavage, cellular morphology, and signal transduction cascades. Such mechanistic experiments are essential for clarifying the contributions of individual caspases to the broader apoptotic program and for validating hypotheses regarding cell fate decisions.

Assay development and validation: Biotin-LEVD-FMK is frequently utilized in the development and optimization of biochemical assays for caspase activity detection. Its dual functionality as both an inhibitor and a labeling reagent makes it ideal for establishing assay sensitivity, specificity, and reproducibility. By providing a reliable tool for positive control experiments and method standardization, it supports the creation of robust platforms for high-throughput screening, basic research, and drug discovery efforts focused on protease regulation.

1. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

2. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

3. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

4. Implications of ligand-receptor binding kinetics on GLP-1R signalling

5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review